Quoin pharmaceuticals submits scientific advice briefing document to ema for its lead asset, qrx003, for netherton syndrome

First step in development process of qrx003 for the eu first step in development process of qrx003 for the eu

QNRX Ratings Summary

QNRX Quant Ranking